National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 9,010 cases where Vaccine is MENB

Case Details

This is page 24 out of 901

Result pages: prev   15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33   next


VAERS ID: 611715 (history)  
Form: Version 1.0  
Age: 20.0  
Sex: Female  
Location: Illinois  
Vaccinated:2015-08-04
Onset:2015-08-04
   Days after vaccination:0
Submitted: 2015-11-11
   Days after onset:99
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 2 UN / SYR

Administered by: Other       Purchased by: Private
Symptoms: Immediate post-injection reaction, Paraesthesia
SMQs:, Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Hypersensitivity (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: ~Meningococcal B (Trumenba)~1~20.00~Sibling
Other Medications: No other medications
Current Illness: None
Preexisting Conditions: 2015, Conjuctivitis; 06/05/2015, Meningococcal group B; Immunisation, Vaccination site pain
Allergies:
Diagnostic Lab Data:
CDC Split Type: 2015263081

Write-up: This is a spontaneous report from a contactable consumer who reported for his 2 daughters. These patients experienced the same events after first and second dose of vaccine. This is the second of 2 reports for the patient 2. A 20-year-old female patient received on 04Aug2015 at 3:30 pm the second single dose of TRUMENBA. Relevant medical history included pink eye from 2015 (Ongoing). Had no allergies. Concomitant medications included birth control pills and antibiotic for Pink eye. The patient received the first dose on 05Jun2015 intramuscular and experienced minimal pain at the injection site. Immediately after second vaccination, the patient felt tingling throughout the body like someone was sticking needles in it. The event lasted for 2 hours. No treatment was provided. Laboratory tests were not performed. The same reactions occurred to her sister after first and second vaccination with meningococcal group b performed respectively on 05Jun2015 and 04Aug2015. Follow up (07Aug2015): New information received from the same contactable consumer includes: details of patient. Follow-up (03OCT2015): Follow-up attempts complete. No further information expected.


VAERS ID: 611716 (history)  
Form: Version 1.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-11-11
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Activities of daily living impaired, Back pain
SMQs:, Retroperitoneal fibrosis (broad), Dementia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: 2015276410

Write-up: This is a spontaneous report from a contactable physician via a Pfizer Sales Representative. A 18-year-old male patient of unknown ethnicity received on an unknown date first single dose of TRUMENBA and first dose of HPV 4 (Merck). The vaccines were administered in different sites. Concomitant medications and medical history were not reported. On unspecified date, the patient had severe back pain and the patient was incapacitated for three days. Outcome was unknown. Follow-up (14OCT2015): Follow-up attempts are completed. No further information is expected.


VAERS ID: 611717 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Rhode Island  
Vaccinated:2015-08-20
Onset:2015-08-21
   Days after vaccination:1
Submitted: 2015-11-11
   Days after onset:82
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 3 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Blood test normal, Erythema, Injection site erythema
SMQs:, Anaphylactic reaction (broad), Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: None
Preexisting Conditions: 02/2015, TRUMENBA, Immunisation, No adverse event, 1st dose; 03/2015, TRUMENBA, Immunisation, No adverse event, 2nd dose
Allergies:
Diagnostic Lab Data: 08/2015, Blood test, normal
CDC Split Type: 2015285546

Write-up: This is a spontaneous report from a contactable physician who reported for her daughter. A 19-year-old female patient of an unspecified ethnicity received third dose of TRUMENBA, intramuscular in the left arm at single dose on 20Aug2015 at 7 PM. The patient medical history and concomitant medications none. Previously the patient received two doses of vaccine in Feb2015 and in Mar2015 without reaction. On 21Aug2015, the patient developed a diffused more like an inflammatory cutaneous response, on her arm. The event was described as "very diffused superficial but erythematous reaction involving more than the injection site. At the time of the third injection it involved a pretty much whole interior surface of her upper arm." The routine blood work performed in Aug2015 (in the following 48 hours) was normal. Event resolved on 25Aug2015. The physician considered that there was a reasonable possibility that the event was related to suspect product. Follow-up (14Sep2015): New information received from a contactable physician includes: Start date for previous vaccinations, time of third dose, anatomical location, physician''s assessment. Follow-up attempts completed. No further information expected.


VAERS ID: 611756 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2015-08-18
Onset:2015-08-18
   Days after vaccination:0
Submitted: 2015-11-11
   Days after onset:85
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH J28923 / 2 RA / IM

Administered by: Private       Purchased by: Private
Symptoms: Chills, Dizziness, Headache, Injected limb mobility decreased, Nervousness, Pain in extremity, Vomiting
SMQs:, Acute pancreatitis (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Vestibular disorders (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: JUNEL FE
Current Illness: Approx. 2 hours after receives vaccine
Preexisting Conditions: 06/02/2015, TRUMENBA, Immunisation, Dose 1
Allergies:
Diagnostic Lab Data:
CDC Split Type: 2015290090

Write-up: The initial case was missing the following minimum criteria: unidentifiable patient. Upon receipt of follow-up information on 14Sep2015, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable medical assistant on behalf of physician, via a Pfizer sales representative. The medical assistant reported for 6 patients. This is the first of the six reports. A 18-year-old female patient of an unspecified ethnicity received second dose of TRUMENBA (Lot# J28923, exp date Jun2016), intramuscular in the right deltoid, on 18Aug2015 at 10:11 am, at 0.5 ml single. Relevant medical history was not reported. Concomitant medication included JUNEL FE from 04May2015 and ongoing daily, for birth control. The patient previously received first dose of TRUMENBA, intramuscular in the right deltoid, on 02Jun2015, at 0.5 ml single. On 18Aug2015, approximately 2 hours after receiving vaccine the patient experienced dizziness, headache (severe), chills, shaky feelings and vomiting. She was advised to increase hydration and lay down/sleep. Events recovered on 19Aug2015. Then on an unspecified date the patient had extreme pain in the arm where the vaccine was injected, like to the point that could barely lift the arm and described it as dead arm; these events lasted about 7 to 10 days after the injection and recovered on an unspecified date. The reporter considered that the adverse events were due to TRUMENBA. Patient will receive TRUMENBA in Dec2015. Follow-up (01Oct2015): New information from the same healthcare professional on behalf of physician includes: vaccination history/scheduling, event details, concomitant.


VAERS ID: 611757 (history)  
Form: Version 1.0  
Age: 20.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2015-08-18
Onset:0000-00-00
Submitted: 2015-11-11
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH J28923 / 2 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Mobility decreased, Pain in extremity
SMQs:, Parkinson-like events (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Extreme arm pain, Unable to lift arm
Preexisting Conditions: 06/02/2015, TRUMENBA, Immunisation, Dose 1; Asthma
Allergies:
Diagnostic Lab Data:
CDC Split Type: 2015290091

Write-up: The initial case was missing the following minimum criteria: unidentifiable patient: Upon receipt of follow-up information on 14Sep2915, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable medical assistant reporting on behalf of a physician via a Pfizer sales representative. The medical assistant reported six reports for six patients. This is the second report. A 20-year-old male patient of an unspecified ethnicity received second dose of TRUMENBA (Lot# J28923, exp date Jun2016), intramuscular in the left deltoid, on 18Aug2015 at 09:58 am, at 0.5 ml single. Relevant medical history included asthma. Concomitant medications were not reported. The patient previously received first dose of TRUMENBA, intramuscular in the left deltoid, on 02Jun3025, at 0.5 ml single. On an unspecified date the patient had extreme arm pain where the vaccine was injected, like to the point that could barely lift the arm described it as dead arm which lasted about 7 to 10 days after the injection. The reporter considered that the adverse events were due to TRUMENBA. Follow-up attempts completed. No further information expected.


VAERS ID: 611759 (history)  
Form: Version 1.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:2015-08-30
Onset:0000-00-00
Submitted: 2015-11-11
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH 43514 / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Blood pressure fluctuation, Bradycardia, Pruritus, Pulse abnormal
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Hypertension (broad), Cardiomyopathy (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Blood pressure measurement, 90 mmHg; Blood pressure measurement, 88/77 mmHg; Blood pressure measurement, 88/60 mmHg; Blood pressure measurement, 110/84 mmHg; Pulse abnormal, 87; Pulse abnormal, 60; Pulse abnormal, 40
CDC Split Type: 2015290718

Write-up: This is a spontaneous report from a contactable consumer via Pfizer employer. A male patient of an unspecified age and ethnicity received TRUMENBA (Lot# 43514 Expiry date: 31Jul2016), via an unspecified route of administration on 30Aug2015 at single dose. The patient medical history and the patient''s concomitant medications were not reported. The patient experienced itching and bradycardia. His blood pressure was 90, then his blood pressure went to 88/60 and then 88/77 at 4:30pm on Aug2015 with outcome of unknown. Pulsation was of 40 and went to 60 at 4:30 pm. All events occurred on unknown date in Aug2015 and the outcome was reported as unknown. The patient received 500cc of normal saline solution and then his pulse went to 87 and blood pressure to 110/84. The Pfizer employee mentioned the patient did not have any past medical history. Follow-up (09Sep2015): Follow-up attempts are completed. No further information is expected.


VAERS ID: 611760 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: California  
Vaccinated:2015-08-20
Onset:2015-08-21
   Days after vaccination:1
Submitted: 2015-11-11
   Days after onset:82
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH J28923 / UNK LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Injection site bruising, Tuberculin test
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Levothyroxine sodium
Current Illness: None
Preexisting Conditions: Autoimmune thyroiditis; Hypothyroidism, for several years, well controlled on Levothyroxine.
Allergies:
Diagnostic Lab Data: 07/23/2015, Tuberculin test
CDC Split Type: 2015291938

Write-up: This is a spontaneous report from a contactable physician via Pfizer sales representative. A 17-year-old female patient of unspecified ethnicity received TRUMENBA (lot number J28923) intramuscular on the left deltoid on 20Aug2015 at 16:30 at single dose, on unknown date. Relevant medical history included Hashimoto''s thyroiditis and hypothyroidism for several years, well controlled on Levothyroxine. Concomitant medication included levothyroxine sodium (manufacturer unknown) at 75 mg daily for hypothyroidism. The patient underwent a TB skin test (manufactured by Sanofi Pasteur) on 23Jul2015. She got an unspecified vaccine on 14Jul2014 without issue. The day after the vaccination, on 21Aug2015, the patient developed bruising that extended from shot area to elbow, considered not serious. The patient recovered from the event on 23Aug2015. The physician reported that the patient provided to him/her information regarding the reported adverse event with the use of the vaccine. The physician considered the Pfizer vaccine had a causal effect to the adverse event. Follow up (13Oct2015): New information reported from the same contactable physician includes: patient''s age, details of the vaccine, medical history, concomitant medication, lab data, outcome, physician''s causality assessment and seriousness. Follow-up attempts completed. No further information expected. Follow-up (21Oct2015): This is a follow-up report combining information from duplicate reports 2015293929 and 2015291938. The current and all subsequent information will be reported under manufacturer report number 2015291938. Follow-up attempts completed. No further information expected.


VAERS ID: 611761 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: California  
Vaccinated:2015-08-25
Onset:0000-00-00
Submitted: 2015-11-11
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH L13515 / UNK LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Back pain, Nausea, Peripheral swelling
SMQs:, Cardiac failure (broad), Acute pancreatitis (broad), Angioedema (broad), Retroperitoneal fibrosis (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: None
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: 2015293034

Write-up: This is a spontaneous report obtained from a contactable physician through a Pfizer sales representative. This physician reported two cases for same drug and different events/patient (brother and sister). This is one of the two reports. A 13-year-old healthy female patient of an unspecified ethnicity received. on 25Aug2015 at 09:30, TRUMENBA (Lot. L13515), intramuscular in the left arm, at 0.5 ml, single dose, for immunization (prevention of type b meningococcal infection). The vaccine was administered at the private doctor''s office/hospital and was purchased with private funds. Relevant medical history and concomitant medications were unknown. The patient experienced nausea, swollen arm and lower back pain on an unspecified date. The events did not require an emergency room or physician visit. No hospitalization was required. The patient recovered from the event, nausea on 30Aug2015; while clinical outcome of the other events was unknown. The case was assessed as non-serious. There was a reasonable possibility that the events were related to meningococcal group b rlp2086. Follow-up (09Oct2015): New information reported from the same contactable physician includes: patient details, suspect drug details, and reaction data. Follow-up attempts obtained. No further information expected.


VAERS ID: 611762 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2015-08-05
Onset:2015-08-07
   Days after vaccination:2
Submitted: 2015-11-11
   Days after onset:96
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH J29203 / UNK LA / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U4998AB / 2 LA / UN

Administered by: Private       Purchased by: Other
Symptoms: Injection site erythema, Pain, Swelling, Tenderness, Vaccination site rash
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LEXAPRO
Current Illness: Unknown
Preexisting Conditions: TDAP; Immunisation, Dose 1
Allergies:
Diagnostic Lab Data:
CDC Split Type: 2015304875

Write-up: This is a spontaneous report from a contactable physician (reporting for the daughter) via a Pfizer sales representative. A 18-year-old female patient received TRUMENBA (Lot # J29203, Exp date Jun2016, NDC number 100000003540), intramuscular in the left deltoid, on 05Aug2015 at 04:30 pm, at 0.5 ml single. Relevant medical history was not reported. Patient did not have illness at time of vaccination. Concomitant medications included TDAP (Lot # U4998AB), intramuscular in the left deltoid, on 05Aug2015; LEXAPRO tablet, oral, at 20 mg daily, for an unspecified indication and unspecified birth control tablets. The patient previously received first dose of TDAP on an unspecified date. The patient experienced tenderness, swelling, generalized aches on 05Aug2015 later in the evening and vaccination site rash (on left upper arm), patchy areas of raised redness on 07Aug2015. Event course was as follows: the patient initially had swelling, tenderness and generalized aches. Rash didn''t show up until 07Aug2015. Rash appeared on left upper arm where injection site was. Rash was patchy areas of raised redness. No discharge. The patient was not admitted to the hospital. Events resolved on 08Aug2015. The reporter considered the reported events as related to TRUMENBA. Follow-up(10Sep2015); New information includes: reporter''s details. Follow-up (28Sep2015): New information received from the same contactable physician includes: causality assessment. Follow-up attempts completed. No further information expected.


VAERS ID: 611763 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-08-30
Onset:2015-08-30
   Days after vaccination:0
Submitted: 2015-11-11
   Days after onset:73
Entered: 2015-11-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / SYR

Administered by: Other       Purchased by: Other
Symptoms: Cough, Decreased appetite, Dizziness, Dysphonia, Feeling abnormal, Influenza like illness, Nasal congestion, Pain, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Anticholinergic syndrome (broad), Dementia (broad), Parkinson-like events (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Vestibular disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LOESTRIN
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: 2015305096

Write-up: This is a spontaneous report from a contactable consumer calling for her daughter. A 18-year-old female patient received first dose of TRUMENBA, via an unspecified route of administration, on 30Aug2015, at single dose, due to outbreak of meningitis in the campus. Relevant medical history was not reported. Concomitant medications included LOESTRIN, at 1x/day, for birth control and MENACTRA, in Aug2015, but was advised it would not cover this strain of outbreak. The patient experienced stuffy nose from 30Aug2015, hoarse voice from unspecified date, cough from unspecified date, no appetite from 30Aug2015, dizzy from 30Aug2015, flu-like symptoms from 30Aug2015, knocked out from 30Aug2015, the shot really hurt from 30Aug2015 and vomiting from 31Aug2015. The patient recovered from all events. The events did not require hospitalization. Patient was seen in the nurses'' station. Therapeutic measures were taken as a result of the events and included treatment with fluids orally on 31Aug2015 at the college, and NYQUIL, DAYQUIL, cough drops/lozenges. The patient received first of three shots of vaccine. Follow-up (06Oct2015): Additional information reported from a contactable consumer includes outcome of the events. Follow up (10Nov2015): New information from a contactable physician included: the physician was not aware of any adverse reaction as he was not the one who administered the vaccine to the patient. Follow-up attempts completed. No further information expected.


Result pages: prev   15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=24&VAX[]=MENB


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166